Multiple Myeloma Drugs Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Multiple Myeloma Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Multiple Myeloma Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Multiple Myeloma Drugs Overall Market Size
2.1 Global Multiple Myeloma Drugs Market Size: 2021 VS 2027
2.2 Global Multiple Myeloma Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Multiple Myeloma Drugs Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Multiple Myeloma Drugs Players in Global Market
3.2 Top Global Multiple Myeloma Drugs Companies Ranked by Revenue
3.3 Global Multiple Myeloma Drugs Revenue by Companies
3.4 Global Multiple Myeloma Drugs Sales by Companies
3.5 Global Multiple Myeloma Drugs Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Multiple Myeloma Drugs Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Multiple Myeloma Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Multiple Myeloma Drugs Players in Global Market
3.8.1 List of Global Tier 1 Multiple Myeloma Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Multiple Myeloma Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Multiple Myeloma Drugs Market Size Markets, 2021 & 2027
4.1.2 Chemotherapy
4.1.3 Corticosteroids
4.1.4 Immunomodulators
4.1.5 Monoclonal Antibodies
4.1.6 Histone Deacetylase (HDAC) Inhibitors
4.1.7 Proteasome Inhibitors
4.1.8 Others
4.2 By Type - Global Multiple Myeloma Drugs Revenue & Forecasts
4.2.1 By Type - Global Multiple Myeloma Drugs Revenue, 2016-2021
4.2.2 By Type - Global Multiple Myeloma Drugs Revenue, 2022-2027
4.2.3 By Type - Global Multiple Myeloma Drugs Revenue Market Share, 2016-2027
4.3 By Type - Global Multiple Myeloma Drugs Sales & Forecasts
4.3.1 By Type - Global Multiple Myeloma Drugs Sales, 2016-2021
4.3.2 By Type - Global Multiple Myeloma Drugs Sales, 2022-2027
4.3.3 By Type - Global Multiple Myeloma Drugs Sales Market Share, 2016-2027
4.4 By Type - Global Multiple Myeloma Drugs Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Multiple Myeloma Drugs Market Size, 2021 & 2027
5.1.2 Men
5.1.3 Women
5.2 By Application - Global Multiple Myeloma Drugs Revenue & Forecasts
5.2.1 By Application - Global Multiple Myeloma Drugs Revenue, 2016-2021
5.2.2 By Application - Global Multiple Myeloma Drugs Revenue, 2022-2027
5.2.3 By Application - Global Multiple Myeloma Drugs Revenue Market Share, 2016-2027
5.3 By Application - Global Multiple Myeloma Drugs Sales & Forecasts
5.3.1 By Application - Global Multiple Myeloma Drugs Sales, 2016-2021
5.3.2 By Application - Global Multiple Myeloma Drugs Sales, 2022-2027
5.3.3 By Application - Global Multiple Myeloma Drugs Sales Market Share, 2016-2027
5.4 By Application - Global Multiple Myeloma Drugs Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Multiple Myeloma Drugs Market Size, 2021 & 2027
6.2 By Region - Global Multiple Myeloma Drugs Revenue & Forecasts
6.2.1 By Region - Global Multiple Myeloma Drugs Revenue, 2016-2021
6.2.2 By Region - Global Multiple Myeloma Drugs Revenue, 2022-2027
6.2.3 By Region - Global Multiple Myeloma Drugs Revenue Market Share, 2016-2027
6.3 By Region - Global Multiple Myeloma Drugs Sales & Forecasts
6.3.1 By Region - Global Multiple Myeloma Drugs Sales, 2016-2021
6.3.2 By Region - Global Multiple Myeloma Drugs Sales, 2022-2027
6.3.3 By Region - Global Multiple Myeloma Drugs Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Multiple Myeloma Drugs Revenue, 2016-2027
6.4.2 By Country - North America Multiple Myeloma Drugs Sales, 2016-2027
6.4.3 US Multiple Myeloma Drugs Market Size, 2016-2027
6.4.4 Canada Multiple Myeloma Drugs Market Size, 2016-2027
6.4.5 Mexico Multiple Myeloma Drugs Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Multiple Myeloma Drugs Revenue, 2016-2027
6.5.2 By Country - Europe Multiple Myeloma Drugs Sales, 2016-2027
6.5.3 Germany Multiple Myeloma Drugs Market Size, 2016-2027
6.5.4 France Multiple Myeloma Drugs Market Size, 2016-2027
6.5.5 U.K. Multiple Myeloma Drugs Market Size, 2016-2027
6.5.6 Italy Multiple Myeloma Drugs Market Size, 2016-2027
6.5.7 Russia Multiple Myeloma Drugs Market Size, 2016-2027
6.5.8 Nordic Countries Multiple Myeloma Drugs Market Size, 2016-2027
6.5.9 Benelux Multiple Myeloma Drugs Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Multiple Myeloma Drugs Revenue, 2016-2027
6.6.2 By Region - Asia Multiple Myeloma Drugs Sales, 2016-2027
6.6.3 China Multiple Myeloma Drugs Market Size, 2016-2027
6.6.4 Japan Multiple Myeloma Drugs Market Size, 2016-2027
6.6.5 South Korea Multiple Myeloma Drugs Market Size, 2016-2027
6.6.6 Southeast Asia Multiple Myeloma Drugs Market Size, 2016-2027
6.6.7 India Multiple Myeloma Drugs Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Multiple Myeloma Drugs Revenue, 2016-2027
6.7.2 By Country - South America Multiple Myeloma Drugs Sales, 2016-2027
6.7.3 Brazil Multiple Myeloma Drugs Market Size, 2016-2027
6.7.4 Argentina Multiple Myeloma Drugs Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Multiple Myeloma Drugs Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Multiple Myeloma Drugs Sales, 2016-2027
6.8.3 Turkey Multiple Myeloma Drugs Market Size, 2016-2027
6.8.4 Israel Multiple Myeloma Drugs Market Size, 2016-2027
6.8.5 Saudi Arabia Multiple Myeloma Drugs Market Size, 2016-2027
6.8.6 UAE Multiple Myeloma Drugs Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Amgen
7.1.1 Amgen Corporate Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Multiple Myeloma Drugs Major Product Offerings
7.1.4 Amgen Multiple Myeloma Drugs Sales and Revenue in Global (2016-2021)
7.1.5 Amgen Key News
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Corporate Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Multiple Myeloma Drugs Major Product Offerings
7.2.4 Johnson & Johnson Multiple Myeloma Drugs Sales and Revenue in Global (2016-2021)
7.2.5 Johnson & Johnson Key News
7.3 Celgene
7.3.1 Celgene Corporate Summary
7.3.2 Celgene Business Overview
7.3.3 Celgene Multiple Myeloma Drugs Major Product Offerings
7.3.4 Celgene Multiple Myeloma Drugs Sales and Revenue in Global (2016-2021)
7.3.5 Celgene Key News
7.4 Takeda Pharmaceutical
7.4.1 Takeda Pharmaceutical Corporate Summary
7.4.2 Takeda Pharmaceutical Business Overview
7.4.3 Takeda Pharmaceutical Multiple Myeloma Drugs Major Product Offerings
7.4.4 Takeda Pharmaceutical Multiple Myeloma Drugs Sales and Revenue in Global (2016-2021)
7.4.5 Takeda Pharmaceutical Key News
7.5 Novartis
7.5.1 Novartis Corporate Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Multiple Myeloma Drugs Major Product Offerings
7.5.4 Novartis Multiple Myeloma Drugs Sales and Revenue in Global (2016-2021)
7.5.5 Novartis Key News
7.6 Daiichi Sankyo
7.6.1 Daiichi Sankyo Corporate Summary
7.6.2 Daiichi Sankyo Business Overview
7.6.3 Daiichi Sankyo Multiple Myeloma Drugs Major Product Offerings
7.6.4 Daiichi Sankyo Multiple Myeloma Drugs Sales and Revenue in Global (2016-2021)
7.6.5 Daiichi Sankyo Key News
7.7 Merck
7.7.1 Merck Corporate Summary
7.7.2 Merck Business Overview
7.7.3 Merck Multiple Myeloma Drugs Major Product Offerings
7.4.4 Merck Multiple Myeloma Drugs Sales and Revenue in Global (2016-2021)
7.7.5 Merck Key News
7.8 AB Science
7.8.1 AB Science Corporate Summary
7.8.2 AB Science Business Overview
7.8.3 AB Science Multiple Myeloma Drugs Major Product Offerings
7.8.4 AB Science Multiple Myeloma Drugs Sales and Revenue in Global (2016-2021)
7.8.5 AB Science Key News
7.9 Teva
7.9.1 Teva Corporate Summary
7.9.2 Teva Business Overview
7.9.3 Teva Multiple Myeloma Drugs Major Product Offerings
7.9.4 Teva Multiple Myeloma Drugs Sales and Revenue in Global (2016-2021)
7.9.5 Teva Key News
7.10 PharmaMar
7.10.1 PharmaMar Corporate Summary
7.10.2 PharmaMar Business Overview
7.10.3 PharmaMar Multiple Myeloma Drugs Major Product Offerings
7.10.4 PharmaMar Multiple Myeloma Drugs Sales and Revenue in Global (2016-2021)
7.10.5 PharmaMar Key News
8 Global Multiple Myeloma Drugs Production Capacity, Analysis
8.1 Global Multiple Myeloma Drugs Production Capacity, 2016-2027
8.2 Multiple Myeloma Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Multiple Myeloma Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Multiple Myeloma Drugs Supply Chain Analysis
10.1 Multiple Myeloma Drugs Industry Value Chain
10.2 Multiple Myeloma Drugs Upstream Market
10.3 Multiple Myeloma Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Multiple Myeloma Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer


List of Tables
Table 1. Key Players of Multiple Myeloma Drugs in Global Market
Table 2. Top Multiple Myeloma Drugs Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Multiple Myeloma Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Multiple Myeloma Drugs Revenue Share by Companies, 2016-2021
Table 5. Global Multiple Myeloma Drugs Sales by Companies, (K Units), 2016-2021
Table 6. Global Multiple Myeloma Drugs Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Multiple Myeloma Drugs Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Multiple Myeloma Drugs Product Type
Table 9. List of Global Tier 1 Multiple Myeloma Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Multiple Myeloma Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Multiple Myeloma Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Multiple Myeloma Drugs Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Multiple Myeloma Drugs Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Multiple Myeloma Drugs Sales (K Units), 2016-2021
Table 15. By Type - Global Multiple Myeloma Drugs Sales (K Units), 2022-2027
Table 16. By Application - Global Multiple Myeloma Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Multiple Myeloma Drugs Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Multiple Myeloma Drugs Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Multiple Myeloma Drugs Sales (K Units), 2016-2021
Table 20. By Application - Global Multiple Myeloma Drugs Sales (K Units), 2022-2027
Table 21. By Region - Global Multiple Myeloma Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Multiple Myeloma Drugs Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Multiple Myeloma Drugs Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Multiple Myeloma Drugs Sales (K Units), 2016-2021
Table 25. By Region - Global Multiple Myeloma Drugs Sales (K Units), 2022-2027
Table 26. By Country - North America Multiple Myeloma Drugs Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Multiple Myeloma Drugs Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Multiple Myeloma Drugs Sales, (K Units), 2016-2021
Table 29. By Country - North America Multiple Myeloma Drugs Sales, (K Units), 2022-2027
Table 30. By Country - Europe Multiple Myeloma Drugs Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Multiple Myeloma Drugs Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Multiple Myeloma Drugs Sales, (K Units), 2016-2021
Table 33. By Country - Europe Multiple Myeloma Drugs Sales, (K Units), 2022-2027
Table 34. By Region - Asia Multiple Myeloma Drugs Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Multiple Myeloma Drugs Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Multiple Myeloma Drugs Sales, (K Units), 2016-2021
Table 37. By Region - Asia Multiple Myeloma Drugs Sales, (K Units), 2022-2027
Table 38. By Country - South America Multiple Myeloma Drugs Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Multiple Myeloma Drugs Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Multiple Myeloma Drugs Sales, (K Units), 2016-2021
Table 41. By Country - South America Multiple Myeloma Drugs Sales, (K Units), 2022-2027
Table 42. By Country - Middle East & Africa Multiple Myeloma Drugs Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Multiple Myeloma Drugs Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Multiple Myeloma Drugs Sales, (K Units), 2016-2021
Table 45. By Country - Middle East & Africa Multiple Myeloma Drugs Sales, (K Units), 2022-2027
Table 46. Amgen Corporate Summary
Table 47. Amgen Multiple Myeloma Drugs Product Offerings
Table 48. Amgen Multiple Myeloma Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 49. Johnson & Johnson Corporate Summary
Table 50. Johnson & Johnson Multiple Myeloma Drugs Product Offerings
Table 51. Johnson & Johnson Multiple Myeloma Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 52. Celgene Corporate Summary
Table 53. Celgene Multiple Myeloma Drugs Product Offerings
Table 54. Celgene Multiple Myeloma Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 55. Takeda Pharmaceutical Corporate Summary
Table 56. Takeda Pharmaceutical Multiple Myeloma Drugs Product Offerings
Table 57. Takeda Pharmaceutical Multiple Myeloma Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 58. Novartis Corporate Summary
Table 59. Novartis Multiple Myeloma Drugs Product Offerings
Table 60. Novartis Multiple Myeloma Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 61. Daiichi Sankyo Corporate Summary
Table 62. Daiichi Sankyo Multiple Myeloma Drugs Product Offerings
Table 63. Daiichi Sankyo Multiple Myeloma Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 64. Merck Corporate Summary
Table 65. Merck Multiple Myeloma Drugs Product Offerings
Table 66. Merck Multiple Myeloma Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 67. AB Science Corporate Summary
Table 68. AB Science Multiple Myeloma Drugs Product Offerings
Table 69. AB Science Multiple Myeloma Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 70. Teva Corporate Summary
Table 71. Teva Multiple Myeloma Drugs Product Offerings
Table 72. Teva Multiple Myeloma Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 73. PharmaMar Corporate Summary
Table 74. PharmaMar Multiple Myeloma Drugs Product Offerings
Table 75. PharmaMar Multiple Myeloma Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 76. Multiple Myeloma Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2019-2021 (K Units)
Table 77. Global Multiple Myeloma Drugs Capacity Market Share of Key Manufacturers, 2019-2021
Table 78. Global Multiple Myeloma Drugs Production by Region, 2016-2021 (K Units)
Table 79. Global Multiple Myeloma Drugs Production by Region, 2022-2027 (K Units)
Table 80. Multiple Myeloma Drugs Market Opportunities & Trends in Global Market
Table 81. Multiple Myeloma Drugs Market Drivers in Global Market
Table 82. Multiple Myeloma Drugs Market Restraints in Global Market
Table 83. Multiple Myeloma Drugs Raw Materials
Table 84. Multiple Myeloma Drugs Raw Materials Suppliers in Global Market
Table 85. Typical Multiple Myeloma Drugs Downstream
Table 86. Multiple Myeloma Drugs Downstream Clients in Global Market
Table 87. Multiple Myeloma Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Multiple Myeloma Drugs Segment by Type
Figure 2. Multiple Myeloma Drugs Segment by Application
Figure 3. Global Multiple Myeloma Drugs Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Multiple Myeloma Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Multiple Myeloma Drugs Revenue, 2016-2027 (US$, Mn)
Figure 7. Multiple Myeloma Drugs Sales in Global Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Multiple Myeloma Drugs Revenue in 2020
Figure 9. By Type - Global Multiple Myeloma Drugs Sales Market Share, 2016-2027
Figure 10. By Type - Global Multiple Myeloma Drugs Revenue Market Share, 2016-2027
Figure 11. By Type - Global Multiple Myeloma Drugs Price (USD/Unit), 2016-2027
Figure 12. By Application - Global Multiple Myeloma Drugs Sales Market Share, 2016-2027
Figure 13. By Application - Global Multiple Myeloma Drugs Revenue Market Share, 2016-2027
Figure 14. By Application - Global Multiple Myeloma Drugs Price (USD/Unit), 2016-2027
Figure 15. By Region - Global Multiple Myeloma Drugs Sales Market Share, 2016-2027
Figure 16. By Region - Global Multiple Myeloma Drugs Revenue Market Share, 2016-2027
Figure 17. By Country - North America Multiple Myeloma Drugs Revenue Market Share, 2016-2027
Figure 18. By Country - North America Multiple Myeloma Drugs Sales Market Share, 2016-2027
Figure 19. US Multiple Myeloma Drugs Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Multiple Myeloma Drugs Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Multiple Myeloma Drugs Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Multiple Myeloma Drugs Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Multiple Myeloma Drugs Sales Market Share, 2016-2027
Figure 24. Germany Multiple Myeloma Drugs Revenue, (US$, Mn), 2016-2027
Figure 25. France Multiple Myeloma Drugs Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Multiple Myeloma Drugs Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Multiple Myeloma Drugs Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Multiple Myeloma Drugs Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Multiple Myeloma Drugs Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Multiple Myeloma Drugs Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Multiple Myeloma Drugs Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Multiple Myeloma Drugs Sales Market Share, 2016-2027
Figure 33. China Multiple Myeloma Drugs Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Multiple Myeloma Drugs Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Multiple Myeloma Drugs Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Multiple Myeloma Drugs Revenue, (US$, Mn), 2016-2027
Figure 37. India Multiple Myeloma Drugs Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Multiple Myeloma Drugs Revenue Market Share, 2016-2027
Figure 39. By Country - South America Multiple Myeloma Drugs Sales Market Share, 2016-2027
Figure 40. Brazil Multiple Myeloma Drugs Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Multiple Myeloma Drugs Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Multiple Myeloma Drugs Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Multiple Myeloma Drugs Sales Market Share, 2016-2027
Figure 44. Turkey Multiple Myeloma Drugs Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Multiple Myeloma Drugs Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Multiple Myeloma Drugs Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Multiple Myeloma Drugs Revenue, (US$, Mn), 2016-2027
Figure 48. Global Multiple Myeloma Drugs Production Capacity (K Units), 2016-2027
Figure 49. The Percentage of Production Multiple Myeloma Drugs by Region, 2020 VS 2027
Figure 50. Multiple Myeloma Drugs Industry Value Chain
Figure 51. Marketing Channels

Amgen
Johnson & Johnson
Celgene
Takeda Pharmaceutical
Novartis
Daiichi Sankyo
Merck
AB Science
Teva
PharmaMar